WAVE Life Sciences Ltd (NAS:WVE)
$ 5.74 0.22 (3.99%) Market Cap: 716.00 Mil Enterprise Value: 590.91 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 63/100

Q1 2020 WAVE Life Sciences Ltd Earnings Call Transcript

May 11, 2020 / 12:30PM GMT
Release Date Price: $10.11 (+26.85%)
Operator

Good morning and welcome to the Wave Life Sciences First Quarter 2020 Conference Call. (Operator Instructions) As a reminder, this call is being recorded and webcast.

I will now turn the call over to Kate Rausch, Head of Investor Relations at Wave Life Sciences. Please go ahead.

Kate Rausch
Wave Life Sciences Ltd. - Head of IR

Thank you, operator. Good morning and thank you for joining us today to discuss our recent business progress and review Wave's first quarter 2020 operating results. On the call with me here today are Dr. Paul Bolno, our President and CEO; David Gaiero, Interim CFO; Dr. Mike Panzara, our Chief Medical Officer; and Dr. Chandra Vargeese, Senior Vice President, Drug Discovery.

This morning, we issued a news release detailing our first quarter results. Please note that this news release is available in the Investors section of our website, www.wavelifesciences.com. The slide presentation that accompanies this webcast will also be available on our

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot